CGRP: the immune system’s double agent – context-dependent roles in inflammation, resolution and cancer
-
By
-
Mushref Bakri Assas
-
July 8, 2026
-
Clinical Scorecard: CGRP: A Dual Role in the Immune System – Contextual Functions in Inflammation, Resolution, and Cancer
At a Glance
| Category | Detail |
|---|
| Condition | CGRP signaling in immune response |
| Key Mechanisms | CGRP acts as an immune modulator with both anti-inflammatory and pro-inflammatory roles depending on the context. |
| Target Population | Individuals with chronic inflammatory conditions, infections, and cancer. |
| Care Setting | Clinical research and immunology |
Key Highlights
- CGRP has dual roles in immune modulation, acting as both an anti-inflammatory and pro-inflammatory agent.
- CGRP signaling is implicated in various conditions including psoriasis, sepsis, and cancer.
- CGRP receptor antagonists may be repurposed for treating conditions driven by dysregulated CGRP signaling.
Guideline-Based Recommendations
Diagnosis
- Assess CGRP levels and receptor expression in relevant immune conditions.
Management
- Consider CGRP receptor antagonists for conditions with elevated CGRP signaling.
Monitoring & Follow-up
- Monitor immune response and inflammation levels in patients receiving CGRP-targeted therapies.
Risks
- Be aware of potential immune suppression when targeting CGRP in chronic inflammatory diseases.
Patient & Prescribing Data
Patients with chronic inflammatory diseases, infections, and cancer.
CGRP receptor antagonists are currently used for migraine and may have broader applications in immune-related conditions.
Clinical Best Practices
- Utilize context-aware targeting of CGRP to maintain physiological homeostasis.
- Incorporate findings from murine models and human correlative studies in treatment planning.
Related Resources & Content
